Skip to main content
Clinical Trials/IRCT20160516027929N11
IRCT20160516027929N11
Recruiting
Phase 2

Comparison of the efficacy and side effects of desloratadine with fexofenadine on allergic rhinitis in patients referred to Masih Daneshvari Hospital

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Allergic rhinitis.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
65
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age over 12 years
  • History of allergic rhinitis or diagnosis at first visit
  • Written consent to participate in the study

Exclusion Criteria

  • Sensitivity, allergy or adverse reaction to desloratadine and fexofenadine
  • Patients who have previously been treated with two or more drugs
  • pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials